Citations

Mayo Clinic

Showing 10 of 108551 citations.

Efficacy of ADIPOR1 and ADIPOR2 peptide‐agonist AdipoRon in preventing contracture in a rabbit model of arthrofibrosis
Carstens, Mason F. , Limberg, Afton K. , Bettencourt, Jacob W. , Payne, Ashley N. , Ryan, Zachary, Berry, Daniel J., Dudakovic, Amel , Berry, Daniel J. , Carstens, Mason , Karczewski, Daniel C, Ryan, Zachary T, Sanchez-Sotelo, Joaquin, Abdel, Matthew P , Berry, Daniel J , Salmons, Harold I. , Payne, Ashley N., Karczewski, Daniel , Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Berry, Daniel J., Abdel, Matthew P.

Journal of Orthopaedic Research | April 12, 2024 | Volume: 42 | Issue: 9 | Pages: 1916-1922

10.1002/jor.25853 | PMID 38605593 Get It

AbstractAdipoRon is an adiponectin receptor 1, 2 (ADIPOR1 and ADIPOR2) agonist with potential antifibrotic effects. Whether AdipoRon can mitigate joint stiffness in a rabbit model of arthrofibrosis is unknown. We examined the efficacy of intravenous (IV) AdipoRon at mitigating contracture in a rabbit model of knee arthrofibrosis. Fifty‐six female New Zealand White rabbits were divided into three dosing groups: vehicle (dimethyl sulfoxide, DMSO), 2.5 mg/kg AdipoRon, and 5 mg/kg AdipoRon. AdipoRon, in DMSO, was administered IV preoperatively and for 5 days postoperatively (30 rabbits, Aim 1). AdipoRon was again dosed similarly after Kirschner wire (K‐wire) removal at 8 weeks (26 rabbits; Aim 2). The primary outcome of joint passive extension angle (PEA,°) was measured at 8, 10, 12, 16, and 24 weeks following index surgery. At 24 weeks, rabbits were euthanized and limbs were harvested to measure posterior capsular stiffness (N cm/°). In Aim 1, the 5 mg/kg treated rabbits had a significant increase in PEA when compared to controls at 16‐week (p < 0.05). In Aim 2, the 5 mg/kg treated rabbits had a significant increase in PEA when compared to controls at 10‐week (p < 0.05). In both aims, no significant differences were observed at later time points. Capsular stiffness was no different in any group. We are the first to report the efficacy of IV AdipoRon in a rabbit model of arthrofibrosis. We identified a significant dose‐dependent decrease in joint PEA at early time points; however, no differences were observed between groups at later time points. Clinical Significance: The present investigation provided the first assessment of AdipoRon's efficacy in mitigating knee stiffness in the current gold standard rabbit model of arthrofibrosis. Results of this investigation provided further evidence as to the potential role of AdipoRon as a preventative for arthrofibrosis in large mammals.
Transcatheter Pulmonary Valve Replacement With the Harmony Valve in Patients Who Do Not Meet Recommended Oversizing Criteria on the Screening Perimeter Plot
McElhinney, Doff B. , Gillespie, Matthew J. , Cabalka, Allison K. , Morray, Brian H. , Balzer, David T. , Qureshi, Athar M. , Hoskoppal, Arvind , Cabalka, Allison , Morray, Brian H , Qureshi, Athar M , Hoskoppal, Arvind K , Goldstein, Bryan H , McElhinney, Doff B , Aboulhosn, Jamil , Goldstein, Bryan H.

Circulation: Cardiovascular Interventions | April 12, 2024 | Volume: 17 | Issue: 5 | Pages: No page available

10.1161/circinterventions.123.013889 | PMID 38606564 Get It

BACKGROUND: Anatomic selection for Harmony valve implant is determined with the aid of a screening report and perimeter plot (PP) that depicts the perimeter-derived radius along the right ventricular outflow tract (RVOT) and projects device oversizing. The PP provides an estimation of suitability for implant, but its sensitivity as a screening method is unknown. This study was performed to describe anatomic features and outcomes in patients who underwent Harmony TPV25 implant despite a PP that predicted inadequate oversizing. METHODS: We reviewed RVOT anatomic features and measurements in patients who underwent transcatheter pulmonary valve replacement with the Harmony TPV25 device despite a PP that predicted inadequate oversizing. RESULTS: This study included 22 patients. There were no unsuccessful implants or adverse valve-related events. Anatomic features varied, but all patients fit into 1 of 3 anatomic types characterized by differences in RVOT dimensions. Type 1 patients (n=9) had a long RVOT with a choke point and a wide main pulmonary artery. Type 2 patients (n=6) had a short RVOT that was pyramidal in shape, with no choke point, and extensive main pulmonary artery lengthening/expansion during systole. Type 3 patients (n=7) had a short, bulbous main pulmonary artery with a choke point and an open pulmonary artery bifurcation. CONCLUSIONS: Transcatheter pulmonary valve replacement with the Harmony valve is feasible in some patients whose PP fit analysis predicts inadequate oversizing. All cases in this series fit into 1 of 3 anatomic patterns, which are not identified in the screening report. Implanters must review cases individually to assess the feasibility of the implant.
Breast Pain Differential: Mondor’s Disease of the Breast
Seemann, LaRae L. , Ardon, Tina, Bowie, Rebecca A, Bullock, Kati C. , Clapp, Adrianna D.M. , Bullock, Catherine , Clapp, Adrianna

Journal of Investigative Medicine High Impact Case Reports | April 12, 2024 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23247096241246621 | PMID 38606534 Get It

Breast pain is a common concern among women in primary care clinics. A rare cause of breast pain is Mondor’s disease (MD), which can present as an acute, painful, erythematous, cord-like induration on the breast or anterior chest wall. The disorder is caused by sclerosing superficial thrombophlebitis of the anterolateral thoracoabdominal wall veins. There does not appear to be a racial or ethnic propensity for this condition; however, it is important to understand that it may be more difficult to see in darker skin types (Fitzpatrick skin types IV-VI) and requires close attention on physical exam. The cause of MD is poorly understood but may be related to direct trauma, strenuous exercise, or hormone changes. We review a case of a 54-year-old woman who presented with an anterior chest wall palpable cord, better visualized with adequate lighting and skin traction, ultimately diagnosed as MD based on clinical findings and imaging studies. Mondor’s disease often resolves spontaneously with supportive care, as in this patient’s case; however, clinicians should be aware of this rare cause of breast pain and its association with hypercoagulable state, vasculitis, and breast cancer.
CircBCL2L13 attenuates cardiomyocyte oxidative stress and apoptosis in cardiac ischemia‒reperfusion injury via miR‐1246/PEG3 signaling
Wu, Hua , Li, Hairui , Song, Jia , Chen, Yongbin , Wang, Ze‐Mu , Jiang, Weipeng , Jiang, Weipeng , Wu, Hua, Zhang, Qian

Journal of Biochemical and Molecular Toxicology | April 12, 2024 | Volume: 38 | Issue: 4 | Pages: No page available

10.1002/jbt.23711 | PMID 38605443 Get It

AbstractIschemia‒reperfusion (I/R) is a common complication in the clinical treatment of acute myocardial infarction (MI), in which cardiomyocytes play a pivotal role in the recovery of cardiac function after reperfusion injury. The expression of numerous circular ribonucleic acids (circRNAs) is disrupted in I/R‐induced cardiac damage, but the potential role of circRNAs in I/R damage has not been fully elucidated. The purpose of the present study was to clarify the biological action and molecular mechanism of circRNA 002166 (also termed circCL2L13) in postmyocardial I/R. Oxygen–glucose deprivation/reoxygenation (OGD/R) in an in vivo model was performed to simulate I/R damage. real‐time polymerase chain reaction analysis was also conducted to evaluate the relationships of the SOD1, SOD2, NRF2, HO1 and GPX4 indicators with oxidative stress injury. TUNEL immunofluorescence was used to evaluate the degree of cardiomyocyte apoptosis in the different treatment groups. The circBCL2L13 level was markedly upregulated in myocardial tissues from a mouse I/R model. Overexpression of circBCL2L13 markedly attenuated the expression of oxidative stress‐related genes and apoptosis in OGD/R‐induced cardiomyocytes. A mechanistic study revealed that circBCL2L13 functions as a ceRNA for miR‐1246 and modulates paternally expressed gene 3 (PEG3). Eventually, circBCL2L13 was proven to regulate PEG3 by targeting miR‐1246, thereby protecting against OGD/R‐induced cardiomyocyte oxidative damage and apoptosis. In conclusion, our study confirmed that the circBCL2L13/miR‐1246/PEG3 axis suppressed the progression of OGD/R injury in cardiomyocytes, which might lead to new therapeutic strategies for cardiac I/R injury.
Left Atrial to Coronary Sinus Shunting for Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Early Feasibility Study 1-Year Results
Urey, Marcus A. , Hibbert, Benjamin , Labinaz, Marino , Wiley, Mark, Gupta, Bhanu , Shah, Hirak , Sorajja, Paul , Pineda, Andrés M. , Missov, Emil, Mahmud, Ehtisham , Kahwash, Rami , Lilly, Scott , Murthy, Sandhya, Fam, Neil , García, Santiago , Chung, Eugene S. , Klein, Liviu , Cheng, Richard K. , Houston, Brian A. , Amoroso, Nicholas , Gafoor, Sameer, Hermiller, James, Aldaia, Lillian , Koulogiannis, Konstantinos , Gray, William A. , Zahr, Firas , Zahr, Firas , Hibbert, Benjamin , Cheng, Richard , Jorde, Ulrich P. , Eckman, Peter , Simard, Trevor , Nazer, Babak , Sauer, Andrew J , Sorajja, Paul , Latib, Azeem , Chang, Lee, Chaudhry, Sunit‐Preet , Schwartz, Jonathan G.

European Journal of Heart Failure | April 12, 2024 | Volume: 26 | Issue: 4 | Pages: 1065-1077

10.1002/ejhf.3241 | PMID 38606485 Get It

Abstract Aims Patients with heart failure and mildly reduced or preserved ejection fraction have limited therapeutic options. The ALT-FLOW Early Feasibility Study evaluated safety, haemodynamics and outcomes for the APTURE transcatheter shunt system, a novel left atrium to coronary sinus shunt in these patients. Methods and results Safety and shunt implantation success was evaluated for all 116 enrolled patients. An analysis population of implanted patients with a left ventricular ejection fraction (LVEF) &gt;40% (n = 95) was chosen to assess efficacy via paired comparison between baseline and follow-up haemodynamic (3 and 6 months), and echocardiographic, clinical and functional outcomes (6 months and 1 year). Health status and quality of life outcomes were assessed using the Kansas City Cardiomyopathy Questionnaire overall summary score (KCCQ-OSS). The primary safety endpoint, major adverse cardiac, cerebral, and renal events, and reintervention through 30 days, occurred in 3/116 patients (2.6%). All implanted shunts were patent at 1 year. In patients with LVEF &gt;40%, the mean (95% confidence interval) reduction in exercise pulmonary capillary wedge pressure (PCWP) at 20 W was −5.7 (−8.6, −2.9) mmHg at 6 months (p &lt; 0.001). At baseline, 8% had New York Heart Association class I–II status and improved to 68% at 1 year (p &lt; 0.001). KCCQ-OSS at baseline was 39 (35, 43) and improved at 6 months and 1 year by 25 (20–30) and 27 (22–32) points, respectively (both p &lt; 0.0001). No adverse changes in haemodynamic and echocardiographic indices of right heart function were observed at 1 year. Overall, the reduction in PCWP at 20 W and improvement in KCCQ-OSS in multiple subgroups were consistent with those observed for the entire population. Conclusions In patients with heart failure and LVEF &gt;40%, the APTURE shunt demonstrated an acceptable safety profile with significant sustained improvements in haemodynamic and patient-centred outcomes, underscoring the need for further evaluation of the APTURE shunt in a randomized trial.
Relapsing IgG4-related disease presenting with unilateral parotid mass and facial palsy
Ahmed, Nehaal , Kimbrough, Bradly, Koster, Matthew, Kimbrough, Bradly A. , Koster, Matthew J.

Rheumatology | April 11, 2024 | Volume: 63 | Issue: 7 | Pages: e204-e205

10.1093/rheumatology/keae224 | PMID 38608192 Get It

Outcome of lung transplantation in patients with pulmonary alveolar microlithiasis in the era of COVID-19 infection
Raavi, Lekhya , Garg, Pankaj , Alomari, Mohammad , Celik, Nafiye Busra , Makey, Ian A. , Thomas, Mathew , Nassar, Aziza , Sareyyüpoğlu, Başar , Jacob, Samuel , Ahmed, Magdy M. El‐Sayed , Thomas, Mathew , Celik, Nafiye B, Pham, Si M. , Nassar, Aziza , Thomas, Mathew , Garg, Pankaj

Journal of Surgical Case Reports | April 11, 2024 | Volume: 2024 | Issue: 4 | Pages: No page available

10.1093/jscr/rjae211 | PMID 38605700 Get It

Abstract Lung transplant recipients are at higher risk of developing COVID-19 infection compared to other solid organ transplants. The risk further increases in the unvaccinated patients. We present a case of a 43-year-old male who underwent bilateral sequential lung transplantation for pulmonary alveolar microlithiasis (PAM) and had an uneventful recovery. However, two years post-transplantation, the patient developed chronic lung allograft dysfunction (CLAD) with bronchiolitis obliterans syndrome and two episodes of COVID-19 infection. During the second episode of COVID-19 infection, the patient developed sepsis and multi-organ dysfunction ultimately resulting in death. Our case report highlights the increased susceptibility of PAM patients’ post-lung transplant to COVID-19 infection. Continuous follow-up of PAM patients’ post-lung transplantation is necessary to prevent unfavorable outcomes.
What clinicians should know about surrogate end points in hematologic malignancies
Maurer, Matthew J. , Maurer, Matthew , Bommier, Côme , Lambert, Jérôme

Blood | April 11, 2024 | Volume: 144 | Issue: 1 | Pages: 11-20

10.1182/blood.2023022269 | PMID 38603637 Get It

Abstract Use of surrogates as primary end points is commonplace in hematology/oncology clinical trials. As opposed to prognostic markers, surrogates are end points that can be measured early and yet can still capture the full effect of treatment, because it would be captured by the true outcome (eg, overall survival). We discuss the level of evidence of the most commonly used end points in hematology and share recommendations on how to apply and evaluate surrogate end points in research and clinical practice. Based on the statistical literature, this clinician-friendly review intends to build a bridge between clinicians and surrogacy specialists.
Burnout in Urological Education: An In-Depth Study of Residents and Fellows in the 2021 AUA Census
Harris, Andrew , Golan, Roei , Kraft, Kate H. , North, Amanda , Meeks, William, Galen, Emily, Helsel, Alexis, Koo, Kevin , North, Amanda C. , Modi, Parth K

Journal of Urology | April 11, 2024 | Volume: 212 | Issue: 1 | Pages: 205-212

10.1097/ju.0000000000003949 | PMID 38603628 Get It

Tilt Table Testing
Dudenkov, Daniel V. , Munipalli, Bala , Cheshire, William P.

JAMA | April 11, 2024 | Volume: 331 | Issue: 17 | Pages: 1494

10.1001/jama.2024.0004 | PMID 38602671 Get It

This Diagnostic Test Interpretation uses a patient case to illustrate tilt table testing, useful for evaluating patients with syncope of unknown cause or postural orthostatic tachycardia syndrome (POTS).